Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

Patient Capital Management's investment thesis on Western Alliance Bancorp ($WAL) — Q4 2023 | Buyside Digest

All Pitches

View Letter Analysis

$WALNYSEWestern Alliance Bancorp

BULL

Patient Capital Management—WAL

Fund Letter

Q4 2023

Published January 17, 2024

View Fund Profile

$81.83USD

+1.1% vs last month

$65.00Pitched

+25.9% since pitch

Market Cap$8.9B

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Technical Chart

From the Fund Letter

Western Alliance was bought amidst the regional banking crisis because its underlying fundamentals remained robust despite market fears of failure. The manager highlighted...

— Christina Siegel Malbon

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

SUBSCRIBE TO BSD RESEARCH ($55/MO)Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $WAL, and what else Patient Capital Management is buying.

Other pitches on $WAL

Other investors who've written on Western Alliance Bancorp

No other institutional pitches found for this ticker yet.

View all $WAL pitches →